You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大成生化科技(00809.HK)長春大合暫停生產 預期對公司財務無重大不利影響
格隆匯 12-16 17:21

格隆匯12月16日丨大成生化科技(00809.HK)公佈,監於非洲豬瘟的影響;中國與美國的貿易糾紛;及長春大合生物技術開發有限公司的生產設施需要定期維修,集團藉此機會自2019年8月起透過暫停生產設施的生產營運以提升定期維修的時間表。長春大合為公司的間接全資附屬公司,主要從事賴氨酸及蛋白賴氨酸等玉米生化產品的生產及銷售。

儘管生產設施的機器大修已於2019年11月底完成,但集團管理層經計及最新市況及該集團的財務狀況後,決定繼續暫停生產設施的生產營運至農曆新年後,暫擬直至2020年2月中旬前後。考慮到長春大合的存貨水平及將近農曆新年前後期間行業淡季需求較低,集團預期長春大合將於恢復生產設施的生產營運前仍能繼續其銷售營運。集團管理層將密切觀察市況,並會就恢復生產設施的生產營運進行可行性分析。

儘管自2019年8月起生產設施的生產營運暫停,但長春大合一直維持其銷售營運至本公告日期。根據該集團的未經審核財務資料,截至2019年9月30日止9個月,長春大合的收益及虧損淨值分別佔集團總收益及虧損淨值的25.3%及37.4%。

董事會認為,由於暫停後經營現金流出減少以致其經營虧損減少,故暫停符合公司及公司股東的整體利益。預期暫停將對集團截至2019年12月31日止年度的財務狀況並無重大不利影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account